Article

Weisenfeld lecturer exemplifies bench-to-bedside research

Early in his career, John V. Forrester, MD, FRCSE, FRCSG, FRCOpth, FARVO, became a clinician scientist when a patient seeking help for vitreous hemorrhage volunteered to serve as a "guinea pig" for Dr. Forrester and his consultant, willing to take part in experimental treatments that might help his vision and that would also allow Dr. Forrester to investigate the question of why a vitreous hemorrhage did not resolve very well. He shared this journey as the recipient of ARVO's Mildred Weisenfeld Award, bestowed Monday night.

Fort Lauderdale, FL-Early in his career, John V. Forrester, MD, FRCSE, FRCSG, FRCOpth, FARVO, became a clinician scientist when a patient seeking help for vitreous hemorrhage volunteered to serve as a “guinea pig” for Dr. Forrester and his consultant, willing to take part in experimental treatments that might help his vision and that would also allow Dr. Forrester to investigate the question of why a vitreous hemorrhage did not resolve very well. He shared this journey as the recipient of ARVO’s Mildred Weisenfeld Award, bestowed Monday night.

After successfully treating that patient and subsequently others with what was then a novel therapy-urokinase-Dr. Forrester found that one question led to another, and his investigations led both to answers and to new lines of research.

In a career spanning more than 40 years since he earned a medical degree in 1970 from Glasgow University in Scotland, Dr. Forrester has never stopped being both clinician and scientist. These interlocking roles have led to numerous discoveries, many in the fields of uveitis and diabetes, countless publications, and recognition.

But while Dr. Forrester, who is at the University of Aberdeen, has trained and mentored many MDs and PhDs who share his interest in translational medicine, he fears that too few of today’s young professionals will take up the mantle of clinician scientists. This role, described as “the individuals who can build bridges across research’s ‘valley of death,’ ” is as essential in the 21st century as before, Dr. Forrester said, but its survival depends on overcoming a set of obstacles. These include competing career prospects, many of which are more financially rewarding, uncertainty in the face of “big science,” and difficulty obtaining research funding.

Dr. Forrester also recommended that residency training should be redesigned to include more exposure to science and research and advocated mentorship programs that would help young doctors learn about the work of clinician scientists. Conversely, he also proposed that scientists spend more time in clinics so that they can see for themselves the need for innovative diagnostic and treatment approaches.

For more articles in this issue of Ophthalmology Times Conference Briefclick here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
Brett Bielory, MD, discusses his poster at the ASCRS annual meeting, which focuses on an under-diagnosed corneal pathology: neurotrophic keratitis.
(Image credit: Ophthalmology Times) Oluwatosin U. Smith talks Glaukomtecken
© 2025 MJH Life Sciences

All rights reserved.